Oramed Pharmaceuticals Completes $5.6 Million Funding to Advance Clinical Trials

JERUSALEM, December 11, 2012 /PRNewswire/ —

Oramed Pharmaceuticals Inc. (OTCBB:ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has completed a capital raise of $4,973,075, net of finder’s fee, priced at $0.37 per unit. Each unit includes one share of stock. Unit […]

Categories: Press Releases|Tags: |

Oramed Pharmaceuticals to Present at the 12th Annual Diabetes Technology Society Meeting in Bethesda, MD, Nov 8-10, 2012

JERUSALEM, November 7, 2012 /PRNewswire/ —

Oramed Pharmaceuticals Inc. (OTCBB: ORMP; www.oramed.com), a developer of oral delivery systems, announced today that results of a study performed using its oral insulin formulation, ORMD-0801, have been accepted for presentation at the 12th Annual Diabetes Technology Society Meeting.  The […]

Categories: Press Releases|Tags: |

Former Johnson & Johnson and Bausch & Lomb Executive, Gerald Ostrov, Joins Oramed Pharmaceuticals’ Board of Directors

JERUSALEM, October 18, 2012 /PRNewswire/ —

Oramed Pharmaceuticals Inc. (OTCBB:ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that Gerald Ostrov, former top executive of Johnson & Johnson and Bausch & Lomb, joined its board as Director.

Mr. Ostrov has a long history of excellence […]

Categories: Press Releases|Tags: |

Oramed Pharmaceuticals to Collaborate With Leading Contract Research Organization Medpace for Phase II FDA Trial on Oral Insulin

Former FDA Director to contribute to the design and implementation of the trial

JERUSALEM, October 3, 2012 /PRNewswire via COMTEX/ –Oramed Pharmaceuticals Inc. (OTCBB:ORMP.OB) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that its subsidiary, Oramed Ltd., has signed an agreement with Medpace, Inc. […]

Categories: Press Releases|Tags: |

Corporate Profile’s CPreports.com Publishes Article by Ray Dirks of Ray Dirks Research on Oramed Pharmaceuticals

Jul 31, 2012 (Marketwire via COMTEX) –Corporate Profile’s financial website www.CPreports.com announces Ray Dirks article on Oramed Pharmaceuticals, Inc. (OTCBB: ORMP) (OTCQB: ORMP).

To view report: www.CPreports.com or http://www.CPreports.com/?p=2213

CPreports.com features Gene Marcial, Ray Dirks and Rob Goldman. The […]

Categories: Press Releases|Tags: |

Oramed Pharmaceuticals Granted 2nd Patent in New Zealand; 3rd Patent for Core Technology on Oral Delivery of Proteins

JERUSALEM, July 11, 2012 /PRNewswire via COMTEX/ –Technology to orally administer medications offers far-reaching impact in healthcare industry

Announcing its third patent approval since the beginning of the calendar year, Oramed Pharmaceuticals Inc. (OTCBB:ORMP.OB) (www . oramed . com), a developer of oral drug delivery systems, […]

Categories: Press Releases|Tags: |

Oramed Pharmaceuticals to Present at the 72nd Scientific Sessions of the American Diabetes Association in Philadelphia, PA, June 8-12, 2012

JERUSALEM, June 4, 2012 /PRNewswire via COMTEX/ –ï”Oramed Pharmaceuticals (OTCBB: ORMP.OB), a developer of oral delivery systems, announced today that its abstract, “Concomitant oral insulin and exenatide therapies significantly curb postprandial glucose in pigs,” which reports on the impact of its oral insulin capsule (ORMD-0801) […]

Categories: Press Releases|Tags: |

Oramed Pharmaceuticals Granted Core Technology Patent in New Zealand

JERUSALEM, May 29, 2012 /PRNewswire via COMTEX/ –Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has received approval for a key patent by the New Zealand Patent Office. The patent, entitled “Methods and Compositions for Oral […]

Categories: Press Releases|Tags: |

Oramed Pharmaceuticals to Present at the 11th National Life Science & Technology Week ILSI-BIOMED Conference; Tel Aviv, Israel, 2012

Oramed to Present on Wednesday, May 23, 2012 at 12:10 p.m. (IDT)

JERUSALEM, Israel, May 21, 2012 /PRNewswire via COMTEX/ –ï”Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB), a developer of oral delivery systems, announced today that it was chosen to present at the 11th National Life Science & […]

Categories: Press Releases|Tags: |

Oramed Pharmaceuticals Granted Israeli Patent for Its Core Technology in Oral Delivery of Proteins

JERUSALEM–(BUSINESS WIRE)–May. 16, 2012–
Marking a major milestone for the company, Oramed Pharmaceuticals Inc.
(OTCBB:ORMP) (www.oramed.com),
a developer of oral drug delivery systems, announced today that […]

Categories: Press Releases|Tags: |